| December 19, 2026 (Sat.) |
| Time |
Agenda |
| 08:30 -09:00 |
報到 Registration |
| 09:00–09:15 |
[開幕致詞/ Opening Remarks]
Taiwan RWE Framework 成果發表 Launch of the Taiwan Real-World Evidence (RWE) Framework
蕭斐元 教授 Prof. Fei-Yuan Hsiao TaSPOR 理事長 President, Taiwan Society for Pharmacoeconomics and Outcome Research 國立臺灣大學臨床藥學研究所 教授 Professor, Graduate Institute of Clinical Pharmacy, National Taiwan University
|
|
主持人 Moderator|蕭斐元 Fei-Yuan Hsiao
TaSPOR 理事長 President, Taiwan Society for Pharmacoeconomics and Outcome Research 國立臺灣大學臨床藥學研究所 教授 Professor, Graduate Institute of Clinical Pharmacy, National Taiwan University
|
| 09:15 - 10:05 |
[專題演講 I/ Keynote Speech I]
「真實世界證據於日本成本效果評估與價格調整之應用:經驗與對亞洲的啟示」 Real-World Evidence in Japan's Cost-Effectiveness Evaluation and Price Adjustment: Experience and Implications for Asia
五十嵐中 Ataru Igarashi 日本慶應義塾大學經營管理研究科 Keio Business School, Keio University, Japan
|
| 10:05 – 10:55 |
[專題演講 II/ Keynote Speech II]
「真實世界資料於醫療科技經濟評估之應用:新加坡經驗與對亞洲的啟示」 Using Real-World Data in the Economic Evaluation of Health Technologies: Singapore's Experience and Implications for Asia
Wee Hwee Lin, PhD 新加坡國立大學蘇瑞福公共衛生學院 副教授;健康介入與政策評估研究中心(HIPER)主任 Associate Professor, Saw Swee Hock School of Public Health, National University of Singapore; Director, Centre for Health Intervention and Policy Evaluation Research (HIPER)
|
| 10:55 - 11:15 |
茶敘/ Coffee Break |
| 11:15 – 12:05 |
[專題演講 III/ Keynote Speech III]
「真實世界證據於東南亞健康政策與健保給付決策之生成與應用:泰國經驗」 Generating and Using Real-World Evidence for Health Policy and Reimbursement Decisions in Southeast Asia: Lessons from Thailand
Parnnaphat Luksameesate, PhD 泰國朱拉隆功大學藥學院社會與行政藥學系 助理教授 Asst. Prof., Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University
|
| 12:05 - 13:30 |
午餐/ Lunch |
| 12:10 - 12:40 |
會員大會 (限定會員參加)/ General Assembly (TaSPOR members only) |
|
主持人 Moderator|柯博升 Bor-Sheng Ko
國立臺灣大學醫學院內科部 教授 Professor, Department of Internal Medicine, National Taiwan University College of Medicine 臺大癌醫中心醫院 血液腫瘤部 主任 Director, Department of Hematological Oncology, National Taiwan University Cancer Center
|
| 13:30 - 14:30 |
[專題演講 I/ Invited Lecture I]
「台灣真實世界資料之實務應用」 Practical Applications of Real-World Data in Taiwana
謝慧敏 Hui-Min Hsieh, PhD 高雄醫學大學公共衛生學系 教授 Professor, Department of Public Health, Kaohsiung Medical University
|
| 14:30 – 15:30 |
[專題演講 II/ Invited Lecture II]
「真實世界證據於健康科技評估(HTA)決策之應用」 Applying Real-World Evidence in HTA Decision-Making
(Speaker invitation in progress) 衛生福利部中央健康保險署 代表 Representative, National Health Insurance Administration (NHIA), Ministry of Health and Welfare
黃莉茵 Li-Yin Huang 財團法人醫藥品查驗中心 資深組長 Senior Division Director, Center for Drug Evaluation (CDE), Taiwan
|
| 15:30 - 15:50 |
茶敘/ Coffee Break |
| 15:50 – 16:50 |
[專題演講 III/ Invited Lecture III]
「產業如何運用真實世界證據支持市場准入」 How Industry Leverages Real-World Evidence to Support Market Access
陳全文 CW Chen 中華民國開發性製藥研究協會 秘書長 Chief Operating Officer, International Research-Based Pharmaceutical Manufacturers Association (IRPMA)
周煦文 Hsu-Wen Chou 中華民國開發性製藥研究協會 主任委員 RWE Consulting Group Expert, International Research-Based Pharmaceutical Manufacturers Association (IRPMA)
|
| 16:55 – 17:00 |
[閉幕致詞/ Closing Remarks]
蕭斐元 教授 Prof. Fei-Yuan Hsiao TaSPOR 理事長 President, Taiwan Society for Pharmacoeconomics and Outcome Research 國立臺灣大學臨床藥學研究所 教授 Professor, Graduate Institute of Clinical Pharmacy, National Taiwan University
|
| 17:00 |
大會結束/ End of Meeting |